CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries

被引:10
作者
Chendi, Bih H. [1 ,2 ]
Tveiten, Hallgeir [3 ]
Snyders, Candice, I [2 ]
Tonby, Kristian [1 ,4 ]
Jenum, Synne [4 ]
Nielsen, Susanne Dam [5 ]
Hove-Skovsgaard, Malene [5 ]
Walzl, Gerhard [2 ]
Chegou, Novel N. [2 ]
Dyrhol-Riise, Anne M. [1 ,4 ]
机构
[1] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway
[2] Stellenbosch Univ, DSI NRF Ctr Excellence Biomed TB Res, Dept Biomed Sci,South African MRC Ctr TB Res, Fac Med & Hlth Sci,Div Mol Biol & Human Genet, Cape Town, South Africa
[3] Oslo Univ Hosp, Dept Pulm Med, Oslo, Norway
[4] Oslo Univ Hosp, Dept Infect Dis, Postbox 4952, N-0424 Oslo, Norway
[5] Univ Copenhagen, Rigshosp, Dept Infect Dis, Copenhagen, Denmark
关键词
TB disease; Latent TB infection; Diagnostics; Host biomarkers; Biosignatures; CCL1; IL-2Ra; HIV; Low endemic countries; IFN-GAMMA; ACTIVE TB; BIOMARKERS; DIAGNOSIS; CELLS; IP-10; IMMUNODEFICIENCY; PERFORMANCE; INDUCTION; ASSAYS;
D O I
10.1016/j.jinf.2021.07.036
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To evaluate the performance of selected host immunological biomarkers in differentiating tuberculosis (TB) disease from latent TB infection (LTBI) in HIV uninfected and infected individuals enrolled in TB low-burden countries. Design: Participants with TB disease (N = 85) and LTBI (N = 150) were recruited from prospective cohorts at hospitals in Norway and Denmark. Plasma concentrations of 54 host markers were assessed by Luminex multiplex immunoassays. Using receiver operator characteristic curves and general discriminant analysis, we determined the abilities of individual and combined biomarkers to discriminate between TB disease and LTBI including when patients were stratified according to HIV infection status. Results: Regardless of the groups compared, CCL1 and IL-2Ra were the most accurate single biomarkers in differentiating TB disease from LTBI. Regardless of HIV status, a 4-marker signature (CCL1+ RANTES+ CRP+ MIP-1a) derived from a training set (n = 155) differentiated TB disease from LTBI in the test set (n = 67) with a sensitivity of 56.0% (95% CI, 34.9-75.6) and a specificity of 85.7% (95% CI, 71.5-94.6). A 5-marker signature derived from the HIV uninfected group (CCL1+ RANTES+ MIP1a+procalcitonin+IP-10) performed in HIV-infected individuals with a sensitivity of 75.0% and a specificity of 96.7% after leave-one-out cross validation. A 2-marker signature (CCL1+ TNF-alpha) identified in HIV-infected persons performed in HIV-uninfected with a sensitivity and specificity of 66.7% and 100% respectively in the test set. Conclusions: Plasma CCL1 and IL-2Ra have potential as biomarkers for differentiating TB disease from LTBI in low TB burden settings unaffected by HIV infection. Combinations between these and other biomarkers in bio-signatures for global use warrant further exploration. (C) 2021 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.
引用
收藏
页码:433 / 443
页数:11
相关论文
共 51 条
  • [1] Pathogenesis, Immunology, and Diagnosis of Latent Mycobacterium tuberculosis Infection
    Ahmad, Suhail
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,
  • [2] Expansion of CD25-Negative Forkhead Box P3-Positive T Cells during HIV and Mycobacterium tuberculosis Infection
    Angerami, Matias T.
    Suarez, Guadalupe V.
    Vecchione, Maria B.
    Laufer, Natalia
    Ameri, Diego
    Ben, Graciela
    Perez, Hector
    Sued, Omar
    Salomon, Horacio
    Quirogal, Maria F.
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [3] Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease
    Awoniyi, Dolapo O.
    Teuchert, Andrea
    Sutherland, Jayne S.
    Mayanja-Kizza, Harriet
    Howe, Rawleigh
    Mihret, Adane
    Loxton, Andre G.
    Sheehama, Jacob
    Kassa, Desta
    Crampin, Amelia C.
    Dockrell, Hazel M.
    Kidd, Martin
    Rosenkrands, Ida
    Geluk, Annemieke
    Ottenhoff, Tom H. M.
    Corstjens, P. L. A. M.
    Chegou, Novel N.
    Walzl, Gerhard
    [J]. JOURNAL OF INFECTION, 2016, 73 (03) : 219 - 230
  • [4] Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis
    Chegou, Novel N.
    Sutherland, Jayne S.
    Namuganga, Anna-Ritah
    Corstjens, Paul L. A. M.
    Geluk, Annemieke
    Gebremichael, Gebremedhin
    Mendy, Joseph
    Malherbe, Stephanus
    Stanley, Kim
    van der Spuy, Gian D.
    Kriel, Magdalena
    Loxton, Andre G.
    Kriel, Belinda
    Simukonda, Felanji
    Bekele, Yonas
    Sheehama, Jacob A.
    Nelongo, Josefina
    van der Vyver, Marieta
    Gebrexabher, Atsbeha
    Hailu, Habteyes
    Esterhuyse, Maria M.
    Rosenkrands, Ida
    Aagard, Claus
    Kidd, Martin
    Kassa, Desta
    Mihret, Adane
    Howe, Rawleigh
    Cliff, Jacqueline M.
    Crampin, Amelia C.
    Mayanja-Kizza, Harriet
    Kaufmann, Stefan H. E.
    Dockrell, Hazel M.
    Ottenhoff, Tom H. M.
    Walzl, Gerhard
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [5] Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB
    Chegou, Novel N.
    Sutherland, Jayne S.
    Malherbe, Stephanus
    Crampin, Amelia C.
    Corstjens, Paul L. A. M.
    Geluk, Annemieke
    Mayanja-Kizza, Harriet
    Loxton, Andre G.
    van der Spuy, Gian
    Stanley, Kim
    Kotze, Leigh A.
    van der Vyver, Marieta
    Rosenkrands, Ida
    Kidd, Martin
    van Helden, Paul D.
    Dockrell, Hazel M.
    Ottenhoff, Tom H. M.
    Kaufmann, Stefan H. E.
    Walzl, Gerhard
    [J]. THORAX, 2016, 71 (09) : 785 - 794
  • [6] Beyond the IFN-gamma horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis
    Chegou, Novel N.
    Heyckendorf, Jan
    Walzl, Gerhard
    Lange, Christoph
    Ruhwald, Morten
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (05) : 1472 - 1486
  • [7] Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area
    Chegou, Novel N.
    Essone, Paulin N.
    Loxton, Andre G.
    Stanley, Kim
    Black, Gillian F.
    van der Spuy, Gian D.
    van Helden, Paul D.
    Franken, Kees L.
    Parida, Shreemanta K.
    Klein, Michel R.
    Kaufmann, Stefan H. E.
    Ottenhoff, Tom H. M.
    Walzl, Gerhard
    [J]. PLOS ONE, 2012, 7 (06):
  • [8] Chegou NN, 2011, EXPERT REV ANTI-INFE, V9, P457, DOI [10.1586/eri.11.23, 10.1586/ERI.11.23]
  • [9] Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: Preliminary report
    Chegou N.N.
    Black G.F.
    Kidd M.
    van Helden P.D.
    Walzl G.
    [J]. BMC Pulmonary Medicine, 9 (1)
  • [10] A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
    Chendi, Bih H.
    Snyders, Candice I.
    Tonby, Kristian
    Jenum, Synne
    Kidd, Martin
    Walzl, Gerhard
    Chegou, Novel N.
    Dyrhol-Riise, Anne M.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12